Leadsynbio to expand L-glufosinate capacity after Series C & C+ rounds

On 8 Feb., Suzhou Lead Biotechnology Co., Ltd. (Leadsynbio) announced that it had completed C & C+ rounds of financing, bringing in USD62.91 million (RMB400 million). The money will facilitate commercialisation of the company's existing products, and...

Herbicides China Monthly Report 202202

www.cnchemicals.com